Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$205.27 USD
+3.94 (1.96%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $205.42 +0.15 (0.07%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 2.49 |
EPS Last Quarter | 2.80 |
Last EPS Surprise | 17.15% |
ABR | 2.22 |
Earnings ESP
|
-2.92% |
---|---|
Current Year | 10.21 |
Next Year | 11.10 |
EPS (TTM) | 10.25 |
P/E (F1) | 20.11 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 994.33M | 1.00B | 4.00B | 4.21B |
# of Estimates | 6 | 6 | 5 | 6 |
High Estimate | 1.07B | 1.10B | 4.04B | 4.52B |
Low Estimate | 969.49M | 970.47M | 3.98B | 4.09B |
Year ago Sales | 1.03B | 1.01B | 4.13B | 4.00B |
Year over Year Growth Est. | -3.15% | -0.99% | -3.13% | 5.13% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.49 | 2.64 | 10.21 | 11.10 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | 2.36 | 2.57 | 9.99 | 10.67 |
High Estimate | 3.00 | 3.25 | 10.90 | 12.28 |
Low Estimate | 2.36 | 2.42 | 9.92 | 10.35 |
Year ago EPS | 2.72 | 2.46 | 10.67 | 10.21 |
Year over Year Growth Est. | -8.46% | 7.32% | -4.31% | 8.71% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 5 | 5 | 8 | 8 |
Down Last 60 Days | 5 | 5 | 8 | 8 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.49 | 2.64 | 10.21 | 11.10 |
7 Days Ago | 2.49 | 2.64 | 10.21 | 11.10 |
30 Days Ago | 3.01 | 3.28 | 10.99 | 12.35 |
60 Days Ago | 3.01 | 3.28 | 11.00 | 12.36 |
90 Days Ago | 3.01 | 3.27 | 11.00 | 12.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.42 | 2.52 | 10.12 | 10.95 |
Zacks Consensus Estimate | 2.49 | 2.64 | 10.21 | 11.10 |
Earnings ESP | -2.92% | -4.58% | -0.85% | -1.33% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.80 | 2.27 | 2.46 | 2.72 | NA |
Estimate | 2.39 | 2.05 | 2.39 | 2.35 | NA |
Difference | 0.41 | 0.22 | 0.07 | 0.37 | 0.27 |
Surprise | 17.15% | 10.73% | 2.93% | 15.74% | 11.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more